{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T21:10:24Z","timestamp":1699996224838},"reference-count":10,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,6,9]],"date-time":"2008-06-09T00:00:00Z","timestamp":1212969600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To outward appearances, the publication of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial has led to a monolithic backlash against the use of ezetimibe by cardiologists for the treatment of hyperlipidemia. Rather than be swayed by popular opinion, we should each put the results of ENHANCE into context and ask the questions: should I put my trust in an imaging surrogate or in low\u2010density lipoprotein (LDL) cholesterol (LDL\u2010C), and how do the safety and efficacy of ezetimibe compare with other nonstatin lipid\u2010lowering agents? Copyright \u00a9 2008 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/clc.20405","type":"journal-article","created":{"date-parts":[[2008,6,9]],"date-time":"2008-06-09T20:53:00Z","timestamp":1213044780000},"page":"288-290","source":"Crossref","is-referenced-by-count":4,"title":["The Implications of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression Trial: A Return to First Principles"],"prefix":"10.1002","volume":"31","author":[{"given":"Kiran","family":"Musunuru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800742"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04053-8"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1344"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.11.018"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000100688.17280.E6"},{"key":"e_1_2_1_7_2","unstructured":"Clinical Trial. IMPROVE\u2010IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe\/Simvastatin) vs Simvastatin. Available fromhttp:\/\/www.clinicaltrials.gov\/show \/NCT00202878 [Accessed 7 April2008]."},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011090"},{"key":"e_1_2_1_9_2","unstructured":"Clinical Trial. AIM HIGH: Niacin Plus Statin to Prevent Vascular Events. Available fromhttp:\/\/www.clinicaltrials.gov\/show\/NCT00120289 [Accessed 7 April2008]."},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67667-2"},{"key":"e_1_2_1_11_2","unstructured":"Clinical Trial. ACCORD: Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Available fromhttp:\/\/www.clinicaltrials.gov\/show\/NCT00000620[Accessed 7 April2008]."}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.20405","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.20405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T20:40:56Z","timestamp":1699994456000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.20405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1002\/clc.20405"],"URL":"https:\/\/doi.org\/10.1002\/clc.20405","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}